All Articles

Ferroptosis-related signaling pathways in cancer drug resistance

Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment

NFE2L2 and ferroptosis resistance in cancer therapy

ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies

Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing

Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer

Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer: strategies for Cold-to-Hot tumor transformation

The epigenetic mechanisms involved in the treatment resistance of glioblastoma

The role and clinical applications of exosomes in cancer drug resistance

Targeting NETosis: nature's alarm system in cancer progression

Recent advanced lipid-based nanomedicines for overcoming cancer resistance

Dysregulation of calcium homeostasis in cancer and its role in chemoresistance

Acquired resistance to molecularly targeted therapies for cancer

Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches

Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers

Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications

Lactylation: a novel driver of drug resistance in the tumor microenvironment